Developer docs
API playgroundTry for free, no card

Search company profiles

Mitsui Global Investment

Full company profile

uuid0005eml

Namestring
Mitsui Global Investment
Legal namestring
Mitsui & Co. Global Investment, Inc.
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Mitsui & Co. Global Investment, Inc. (MGI) is a private venture capital firm and wholly-owned subsidiary of Mitsui & Co., Ltd., one of Japan's largest diversified trading conglomerates (sogo shosha). Founded in 2001 as Mitsui & Co. Venture Partners (MCVP) in New York, the firm rebranded to MGI in 2010 and is currently headquartered at 64 Willow Place, Suite 200, Menlo Park, California, with a regional office in Tokyo. MGI invests in early-stage and growth-stage companies, primarily in healthcare and technology, providing equity capital alongside strategic guidance and access to Mitsui & Co.'s global corporate network. Over 20 years, MGI has invested in 100+ portfolio companies and realized 35+ exits through IPOs, M&As, and SPAC mergers, with notable outcomes including RallyBio, Valens Semiconductor, Spire Global, Cipia, Kaltura, and QD Laser. The firm has expanded its platform through two related venture entities: Magenta Venture Partners (2018) and E12 Ventures (2022), and operates an investment team in Israel in addition to its US and Tokyo presence. Its Beijing office, established in 2007, was closed on September 30, 2024, after 17 years of operation, narrowing its on-the-ground Asia footprint. MGI does not sell products or services; its revenue is generated from investment management activities (management fees, carried interest, and direct investment returns) funded by capital allocated from its parent company, with no public disclosure of AUM or financial results.

Short descriptiontext

Mitsui Global Investment (MGI) is a venture capital subsidiary of Mitsui & Co., Ltd., investing in early-stage healthcare and technology companies. Headquartered in Menlo Park with a Tokyo office, MGI has backed 100+ portfolio companies and realized 35+ exits across IPOs, M&As, and SPAC mergers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMenlo Park, United States
HQ citystring
Menlo Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital, early-stage investment, startup financing, growth equity, portfolio management
Industry1 code
1Corporate Strategic Real Assets & Infrastructure Venture Investing
CodeFSANAHANPrimaryYes
NAICS code2 codes
  • Portfolio Management and Investment Advice52394
  • All Other Financial Investment Activities52399
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
No data
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Mitsui Global Investment is a venture capital firm that invests equity capital in early-stage and growth-stage startups, primarily in technology and healthcare sectors. Beyond financial backing, MGI provides portfolio companies with strategic guidance, mentorship, and access to the global commercial network of its parent company Mitsui & Co. The firm invests directly through equity rounds and also operates affiliated vehicles Magenta Venture Partners and E12 Ventures.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Mitsui Global Investment (MGI) is a venture capital and investment firm. As an investment company, it does not offer software products or technology services in the traditional sense. The company provides venture capital financing, strategic guidance, and support to portfolio companies across technology and healthcare sectors. MGI's offering consists of investment management services, not packaged software products or SaaS platforms.

Product and service4 records
1Early-stage venture capital investment
CategoryVenture Capital
2Strategic guidance and global network access
CategoryVenture Capital
3Magenta Venture Partners fund
CategoryVenture Capital
4E12 Ventures fund
CategoryVenture Capital
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-01-01
Description

Cipia, a portfolio company of MGI, expanded its partnership with Ambarella to make Cipia's Driver Sense driver monitoring software available on Ambarella's system-on-a-chip (SoC) platforms. This enables automotive OEMs to integrate driver monitoring capabilities using Ambarella's edge AI semiconductor platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-06-17
Description

Cipia, an MGI portfolio company, partnered with Intcomex, the leading platform for value-added solutions and technology products in Latin America and the Caribbean, to meet growing demand for video telematics and driver monitoring solutions in LATAM commercial fleets markets.

Recent move21 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight10 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The corporate venture capital arm of Toyota, focused on early-stage startups in mobility, AI, autonomy, and sustainability. Highly comparable to MGI as a Japanese corporate-backed, early-stage CVC investing from Silicon Valley across frontier technologies.

TypeDirect peer
Description

Honda's Silicon Valley-based CVC arm investing in mobility, energy, and AI startups. Directly comparable to MGI as a Japanese-conglomerate-backed venture unit using a US innovation hub to source strategic deals.

TypeDirect peer
Description

The venture capital arm of Mitsubishi UFJ Financial Group, one of Japan's largest financial conglomerates. Comparable to MGI as a Japanese-conglomerate-controlled VC investing in early- and growth-stage companies with a strategic lens.

TypeDirect peer
Description

The corporate venture and private equity arm of Daiwa Securities Group, focused on Japanese and cross-border growth investments. Comparable as a Japanese diversified financial group-affiliated investment firm with both VC and growth mandates.

TypeDirect peer
Description

One of Japan's largest venture capital firms and a subsidiary of SBI Holdings. Comparable to MGI as a Japan-headquartered VC with broad early-stage portfolios, multiple fund vehicles, and global LP/co-investor networks.

TypeBroad incumbent
Description

Manager of the SoftBank Vision Fund, the largest Japanese technology investment platform. Comparable to MGI as a Japan-rooted global technology investor, though substantially larger in scale and capital base.

TypeBroad incumbent
Description

Strategic CVC arm of Salesforce, investing in enterprise software, AI, and digital health startups. MGI's participation alongside Salesforce in the Ellipsis Health round illustrates their shared ecosystem; both apply corporate strategic capital to early-stage innovation.

TypeBroad incumbent
Description

The corporate venture capital arm of Intel, with deep investments in semiconductors, AI, and deep tech — areas that overlap MGI's portfolio (e.g., Valens Semiconductor). Comparable as a long-running US-based tech CVC with similar thematic coverage.

TypeBroad incumbent
Description

Strategic CVC arm of Qualcomm, focused on AI, automotive, IoT, and semiconductors. Comparable to MGI as a tech CVC pursuing similar semiconductor, automotive, and computer-vision themes (e.g., MGI's Cipia and Valens Semiconductor investments).

TypeEmerging player
Description

NVIDIA's corporate venture arm, actively investing in AI, healthcare, and frontier technology startups. Comparable to MGI as a corporate strategic investor in AI-native biotech and digital health themes, though typically writing larger, later-stage checks.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment164 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mitsui Global Investment

Venture Capitalmitsui-global.com

Mitsui Global Investment (MGI) is a venture capital subsidiary of Mitsui & Co., Ltd., investing in early-stage healthcare and technology companies. Headquartered in Menlo Park with a Tokyo office, MGI has backed 100+ portfolio companies and realized 35+ exits across IPOs, M&As, and SPAC mergers.

What Mitsui Global Investment does

Mitsui & Co. Global Investment, Inc. (MGI) is a private venture capital firm and wholly-owned subsidiary of Mitsui & Co., Ltd., one of Japan's largest diversified trading conglomerates (sogo shosha). Founded in 2001 as Mitsui & Co. Venture Partners (MCVP) in New York, the firm rebranded to MGI in 2010 and is currently headquartered at 64 Willow Place, Suite 200, Menlo Park, California, with a regional office in Tokyo. MGI invests in early-stage and growth-stage companies, primarily in healthcare and technology, providing equity capital alongside strategic guidance and access to Mitsui & Co.'s global corporate network. Over 20 years, MGI has invested in 100+ portfolio companies and realized 35+ exits through IPOs, M&As, and SPAC mergers, with notable outcomes including RallyBio, Valens Semiconductor, Spire Global, Cipia, Kaltura, and QD Laser. The firm has expanded its platform through two related venture entities: Magenta Venture Partners (2018) and E12 Ventures (2022), and operates an investment team in Israel in addition to its US and Tokyo presence. Its Beijing office, established in 2007, was closed on September 30, 2024, after 17 years of operation, narrowing its on-the-ground Asia footprint. MGI does not sell products or services; its revenue is generated from investment management activities (management fees, carried interest, and direct investment returns) funded by capital allocated from its parent company, with no public disclosure of AUM or financial results.

Mitsui Global Investment firmographics

Firmographics
Name
Mitsui Global Investment
Legal name
Mitsui & Co. Global Investment, Inc.
Website
https://mitsui-global.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
Mitsui Global Investment (MGI) is a venture capital subsidiary of Mitsui & Co., Ltd., investing in early-stage healthcare and technology companies. Headquartered in Menlo Park with a Tokyo office, MGI has backed 100+ portfolio companies and realized 35+ exits across IPOs, M&As, and SPAC mergers.
Ownership category
akta.pro rank

Mitsui Global Investment industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (52394), All Other Financial Investment Activities (52399)
SIC
Investment Advice (6282)
akta.pro primary industry
Corporate Strategic Real Assets & Infrastructure Venture Investing (FSANAHAN)

Keywords

  • Venture capital
  • Early-stage investment
  • Startup financing
  • Growth equity
  • Portfolio management

Where Mitsui Global Investment is headquartered

Location

Headquarters

HQ city
Menlo Park
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Mitsui Global Investment business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Distribution channels1 record

Marketing channels3 records

Mitsui Global Investment product offering

Product offering

Core offering

Mitsui Global Investment is a venture capital firm that invests equity capital in early-stage and growth-stage startups, primarily in technology and healthcare sectors. Beyond financial backing, MGI provides portfolio companies with strategic guidance, mentorship, and access to the global commercial network of its parent company Mitsui & Co. The firm invests directly through equity rounds and also operates affiliated vehicles Magenta Venture Partners and E12 Ventures.

Product overview

Mitsui Global Investment (MGI) is a venture capital and investment firm. As an investment company, it does not offer software products or technology services in the traditional sense. The company provides venture capital financing, strategic guidance, and support to portfolio companies across technology and healthcare sectors. MGI's offering consists of investment management services, not packaged software products or SaaS platforms.

Differentiator

Problem solved

Functional benefit

Products and services

  • Early-stage venture capital investment
  • Strategic guidance and global network access
  • Magenta Venture Partners fund
  • E12 Ventures fund

Companies that use Mitsui Global Investment

Customer profile

Segments1 record

Ideal customer profiles1 record

Mitsui Global Investment technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Mitsui Global Investment partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Ambarella, Inc.coreTechnology or Integration · 1 January 2022Cipia, a portfolio company of MGI, expanded its partnership with Ambarella to make Cipia's Driver Sense driver monitoring software available on Ambarella's system-on-a-chip (SoC) platforms. This enables automotive OEMs to integrate driver monitoring capabilities using Ambarella's edge AI semiconductor platform.
  • IntcomexcoreChannel Partner/ Reseller/ Distributor · 17 June 2021Cipia, an MGI portfolio company, partnered with Intcomex, the leading platform for value-added solutions and technology products in Latin America and the Caribbean, to meet growing demand for video telematics and driver monitoring solutions in LATAM commercial fleets markets.

Scale indicators3 records

Recent moves21 records

Expansion highlights10 records

Mitsui Global Investment competitors and assessment

Company assessment

Direct peers

  • Toyota Ventures: The corporate venture capital arm of Toyota, focused on early-stage startups in mobility, AI, autonomy, and sustainability. Highly comparable to MGI as a Japanese corporate-backed, early-stage CVC investing from Silicon Valley across frontier technologies.
  • Honda Innovations: Honda's Silicon Valley-based CVC arm investing in mobility, energy, and AI startups. Directly comparable to MGI as a Japanese-conglomerate-backed venture unit using a US innovation hub to source strategic deals.
  • Mitsubishi UFJ Capital: The venture capital arm of Mitsubishi UFJ Financial Group, one of Japan's largest financial conglomerates. Comparable to MGI as a Japanese-conglomerate-controlled VC investing in early- and growth-stage companies with a strategic lens.
  • Daiwa Corporate Investment: The corporate venture and private equity arm of Daiwa Securities Group, focused on Japanese and cross-border growth investments. Comparable as a Japanese diversified financial group-affiliated investment firm with both VC and growth mandates.
  • SBI Investment: One of Japan's largest venture capital firms and a subsidiary of SBI Holdings. Comparable to MGI as a Japan-headquartered VC with broad early-stage portfolios, multiple fund vehicles, and global LP/co-investor networks.

Broad incumbents

  • SoftBank Investment Advisers: Manager of the SoftBank Vision Fund, the largest Japanese technology investment platform. Comparable to MGI as a Japan-rooted global technology investor, though substantially larger in scale and capital base.
  • Salesforce Ventures: Strategic CVC arm of Salesforce, investing in enterprise software, AI, and digital health startups. MGI's participation alongside Salesforce in the Ellipsis Health round illustrates their shared ecosystem; both apply corporate strategic capital to early-stage innovation.
  • Intel Capital: The corporate venture capital arm of Intel, with deep investments in semiconductors, AI, and deep tech — areas that overlap MGI's portfolio (e.g., Valens Semiconductor). Comparable as a long-running US-based tech CVC with similar thematic coverage.
  • Qualcomm Ventures: Strategic CVC arm of Qualcomm, focused on AI, automotive, IoT, and semiconductors. Comparable to MGI as a tech CVC pursuing similar semiconductor, automotive, and computer-vision themes (e.g., MGI's Cipia and Valens Semiconductor investments).

Emerging players

  • NVIDIA Ventures: NVIDIA's corporate venture arm, actively investing in AI, healthcare, and frontier technology startups. Comparable to MGI as a corporate strategic investor in AI-native biotech and digital health themes, though typically writing larger, later-stage checks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Mitsui Global Investment compliance and trust

Trust signal

Compliance2 records

Mitsui Global Investment financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mitsui Global Investment leadership team

Management profile

Number of profiles

Profiles11 records

Mitsui Global Investment subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Mitsui Global Investment funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mitsui Global Investment M&A and investment

M&A and investment

M&A

Investments164 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mitsui Global Investment

What does Mitsui Global Investment do?

Mitsui Global Investment is a venture capital firm that invests equity capital in early-stage and growth-stage startups, primarily in technology and healthcare sectors. Beyond financial backing, MGI provides portfolio companies with strategic guidance, mentorship, and access to the global commercial network of its parent company Mitsui & Co. The firm invests directly through equity rounds and also operates affiliated vehicles Magenta Venture Partners and E12 Ventures.

Is Mitsui Global Investment a public or private company?

Mitsui Global Investment is a private company. It is classified as corporate owned and is currently operating.

When was Mitsui Global Investment founded?

Mitsui Global Investment was founded in 2001. It employs 11 to 50 people.

Where is Mitsui Global Investment based?

Mitsui Global Investment is headquartered in Menlo Park, United States, in the North America region.

Who are Mitsui Global Investment's main competitors?

Direct peers on record are Toyota Ventures, Honda Innovations, Mitsubishi UFJ Capital, Daiwa Corporate Investment and SBI Investment. Broad incumbents are SoftBank Investment Advisers, Salesforce Ventures, Intel Capital and Qualcomm Ventures. NVIDIA Ventures is listed as an emerging player.

Does Mitsui Global Investment have an API?

No public API is recorded for Mitsui Global Investment.

What industry is Mitsui Global Investment in?

Mitsui Global Investment's product category is Venture Capital. Its primary akta.pro industry code is FSANAHAN, Corporate Strategic Real Assets & Infrastructure Venture Investing. Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechStartupsVenture Capital & Startup Funding Roundup, June 2, 2026On June 2, 2026, venture capital funding concentrated on startups addressing physical bottlenecks and regulated markets, including Impulse Space's $500 million Series D and Mach Industries' $300 million Series C. The rounds reflect investor preference for AI tied to workflow control, reimbursement leverage, or measurable operating outcomes, with capital flowing into space mobility, defense manufacturing, healthcare, and fleet electrification.TechStartupsThe U.S. government wants to see AI models before you do. Trump just signed an executive order requesting early accessPresident Trump signed an executive order requiring AI companies to give the federal government access to covered frontier models up to 30 days before public release. The order establishes a benchmarking process to identify such models, with confidentiality and IP protections. It does not create mandatory licensing or preclearance for new AI products.BioSpaceWaypoint Bio Raises $20M Series A Led by Amplify Partners to Advance AI-Designed Cell Therapies Toward the ClinicWaypoint Bio closed a $20M Series A led by Amplify Partners to advance its AI-designed CAR T therapies. The funding will support the WAY-103 program's investigator-initiated trial starting late 2026 and expand its platform. The company also advances WAY-200 for colorectal cancer and preclinical development of other solid-tumor constructs.FinSMEsWaypoint Bio Raises $20M in Series A FundingWaypoint Bio raised $20M in Series A funding led by Amplify Partners, with participation from General Catalyst, Time BioVentures, Mitsui Global Investments, Lux Capital, and Hummingbird Ventures. The company will use the funds to advance its lead WAY-103 program into clinical trials, push WAY-200 for colorectal cancer, and expand spatial biology infrastructure. Its lead program showed a 15-fold potency increase in animal models.VC News DailyWaypoint Bio Raises $20M Series AWaypoint Bio closed a $20 million Series A financing round led by Amplify Partners and Elliot Hershberg. The company's lead program is an in vivo CAR T asset with clinical entry in China expected in late 2026. The round also included participation from General Catalyst, Time BioVentures, Mitsui Global Investments, and Lux Capital.TechStartupsVenture Capital & Startup Funding Roundup, June 1, 2026On June 1, 2026, several startups raised capital, including Maxwell Power's $750 million commitment, DriveNets' $410 million Series D, and Tripo AI's nearly $200 million. The rounds target infrastructure and data layers, with investors backing network fabric, robotics data, and energy deployment.Venture Capital Access OnlineWaypoint Bio Raises $20M Series A Led by Amplify Partners to Advance AI-Designed Cell Therapies Toward the ClinicWaypoint Bio closed a $20M Series A led by Amplify Partners to advance its AI-designed CAR T therapies. The funding will support an investigator-initiated trial for WAY-103 in late 2026 and expand its platform. The company also advances WAY-200 for colorectal cancer.TechStartupsAnthropic confidentially files for IPO at nearly $1 trillion valuation, setting the stage for the biggest AI listing yetAnthropic confidentially filed for an IPO with the SEC, following a $65B funding round that valued it at $965B. The filing could make it one of the most valuable public companies, with OpenAI also preparing a confidential filing.AxiosThe evolving electric bus marketProterra and Mitsui are expanding a battery leasing program for electric buses, with Mitsui providing $200 million. The 12-year leases aim to lower upfront costs, bringing electric buses to roughly diesel prices. The venture is the first of its kind in North American public transit.FinSMEsData Science & Tech Company Black Swan Data Closes £6.2m Series B RoundBlack Swan Data, a London-based data science firm, raised £6.2m in Series B funding from Albion Ventures, Blackstone, and Mitsui. The company will use the funds to accelerate international growth, expand its product platform, and complete its senior management team. Founded in 2011, it serves clients like PepsiCo and Vodafone.